Sartar Therapeutics

Sartar Therapeutics develops targeted therapies for rare diseases such as sarcoma.

Funding rounds

10/2020, 10/2025

Valuation after latest round

€13.4 million

Springvest's ownership stake

4.0% (30 June 2026)

Sector

Life sciences

Sartar Therapeutics website

Explore other companies

Basemark logo
Norsepower logo
Dispelix logo
Volare logo
CurifyLabs logo
Varjo Technologies logo
TILT Biotherapeutics logo
ReOrbit logo
Kuva Space logo
Desentum logo
Eagle Filters Group (Cleantech Invest) logo
TribeStudios logo
Sensapex logo
Edzcom (Ukkoverkot) logo
Leadoo Marketing Technologies logo
9solutions logo
Convion logo
Piceasoft logo
Mobidiag logo
Tosi (Tosibox) logo
Uplause logo
Vivago logo
Mcare logo
Morelex logo
Claned logo
Northern Antibiotics logo
Lekane logo
Musopia logo
Sofica logo
Solar Foods logo
publicly listed
QuantrolOx logo
Earth House logo
Ginolis logo
Finbiosoft logo
Cerenion logo
ArcDia logo
NewIcon logo
Karsa logo
Tenboron logo
Medixine logo
Sulapac logo
Tamturbo logo
Verge Motorcycles logo
Donut Lab logo
ESOX Group logo
Optitune logo
Rocsole logo
Pesmel logo
Uniogen logo
Bioretec logo
publicly listed
Paptic logo
Vapaus logo
Osgenic logo
MedicubeX logo
1/1